Thomas Muster, speaking at World Influenza Congress Europe 2011

Thomas Muster,
CEO / CSO
Avir Green Hills Biotechnology AG

Dr. Thomas Muster is CEO/CSO and co-founder of AVIR Green Hills Biotechnology. He obtained his PhD in Biotechnology from the University of Natural Resources and Applied Life Sciences in Vienna and is Associate Professor for Virology. Prior to AVIR Green Hills Dr. Muster worked as a Research Fellow at the Mount Sinai School of Medicine in New York and was Head of Viral Oncology at the Department of Dermatology at the Medical University in Vienna. Dr. Muster contributed to several key inventions in vaccine development such as the discovery of a conserved antigen on HIV and the interferon antagonist NS1 of influenza virus. Thomas has also co-authored more than forty publications in the field of virology.

Appearing:

Congress Day 2 – Wednesday 7th December 2011

2.10pm